Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel,

Slides:

Advertisements

Similar presentations

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Advertisements

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population Richard K. Cheng, MD, MS,

New-onset Atrial Fibrillation Predicts Heart Failure Progression

EMPA-REG OUTCOME: The Endocrinologist's Point of View

Catherine W. Gillespie, PhD, MPH, Pamela E. Morin, MBA

Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review Shelley R. Salpeter, MD, Jacob S.

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis Islam Y. Elgendy,

Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure

EMPA-REG OUTCOME: The Endocrinologist's Point of View

30-Day Readmissions After an Acute Kidney Injury Hospitalization

Digoxin Use and Lower 30-day All-cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure Ali Ahmed, MD, MPH, Robert C. Bourge, MD,

Nancy M. Albert, PhD, Gregg C. Fonarow, MD, William T

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Increased late mortality after coronary artery bypass surgery complicated by isolated new-onset atrial fibrillation: A comprehensive propensity-matched.

Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks Sripal Bangalore, MD, MHA, Gbenga Ogedegbe,

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Body Mass Index and Mortality in Acute Myocardial Infarction Patients

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Use of Targeted Temperature Management After Out-of-hospital Cardiac Arrest: A Meta- Analysis of Randomized Controlled Trials Ahmed Mahmoud, MD, Islam.

Sabina Hunziker, MD, MPH, Jennifer Stevens, MD, MS, Michael D

Repeated Heart Rate Measurement and Cardiovascular Outcomes in Left Ventricular Systolic Dysfunction Victoria Hamill, PhD, Ian Ford, PhD, Kim Fox, MD,

Age and Gender Differences in Quality of Care and Outcomes for Patients with ST- segment Elevation Myocardial Infarction Sripal Bangalore, MD, MHA, Gregg.

Jane S. Saczynski, PhD, Darleen Lessard, MS, Frederick A

Vasiliki V. Georgiopoulou, MD, Andreas P. Kalogeropoulos, MD, Bruce M

Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery Sun Kyun Ro, MD, Joon Bum Kim, MD, Sung Ho Jung, MD,

Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation Nasir Shariff, MD, Ravi V. Desai, MD, Kanan Patel,

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease Renato D. Lopes, MD, MHS, PhD, Meena Rao, MD,

Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review Elliot B. Tapper, MD, Alan Bonder,

Characteristics of Contemporary Patients Discharged From the Hospital After an Acute Coronary Syndrome Robert J. Goldberg, PhD, Jane S. Saczynski, PhD,

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study Vasilios Papademetriou, MD, DSc, Eric.

Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis Nicolas Rodondi, MD, MAS, Drahomir Aujesky, MD, MS, Eric Vittinghoff,

The Impact of Prior Heart Failure Hospitalizations on Long-term Mortality Differs by Baseline Risk of Death Naga V.A. Kommuri, MD, Todd M. Koelling,

The Natural Course of Microalbuminuria among African Americans with Type 2 Diabetes: A 3-Year Study Mohamed G. Atta, MD, MPH, Kesha Baptiste-Roberts,

Repeated Hemoglobin A1C Ordering in the VA Health System

Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High- Sensitivity Cardiac Troponin I Yader Sandoval, MD, Stephen W. Smith,

Molly E. Waring, PhD, Jane S

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Volume 94, Issue 3, Pages (September 2018)

Preadmission statin use improves the outcome of less severe sepsis patients - a population-based propensity score matched cohort study M.G. Lee, C.-C.

Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study Li Wei, Ph.D., Thomas MacDonald, M.D.,

In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia Todd R. Vogel, MD, MPH, Viktor.

The Reply The American Journal of Medicine

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Impact of Resident Workload and Handoff Training on Patient Outcomes

Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN) Kristi Reynolds, PhD, Alan S. Go, MD, Thomas.

Clinical Outcomes After Treatment of Cocaine-Induced Chest Pain with Beta-Blockers: A Systematic Review and Meta-Analysis Kevin Bryan Lo, MD, Hafeez.

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Jennifer Tjia, MD, MSCE, Jeroan Allison, MD, Jane S

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction Marjan Mujib, MD, MPH, Kanan Patel, MBBS, MPH,

Prevalence and Risk Factors for Erectile Dysfunction in the US

Nilay S. Shah, MD, MPH, David Leonard, PhD, Carrie E

Sarah C. Snow, MD, Gregg C. Fonarow, MD, Joseph A

Statin Use and Risk of COPD Exacerbation Requiring Hospitalization

Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S

Ali Ahmed, MD, MPH, Michael W. Rich, MD, Michael Zile, MD, Paul W

Ali Ahmed, MD, Gregg C. Fonarow, MD, Yan Zhang, MS, MSPH, Paul W

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Devraj Sukul, MD, Shashank S. Sinha, MD, MSc, Andrew M

The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis Giovanni Corona, MD, PhD, Corinna Giuliani, MD, Gabriele Parenti, MD, PhD, Giorgio.

Baseline Q Waves and Time From Symptom Onset to ST-segment Elevation Myocardial Infarction: Insights From PLATO on the Influence of Sex Naji Kholaif,

Francisco Alcocer, MD, Marjan Mujib, MD, Bruce Lowman, MD, Mark A

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Presentation transcript:

Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure Cherinne Arundel, MD, Phillip H. Lam, MD, Rahul Khosla, MD, Marc R. Blackman, MD, Gregg C. Fonarow, MD, Charity Morgan, PhD, Qing Zeng, PhD, Ross D. Fletcher, MD, Javed Butler, MD, MPH, MBA, Wen-Chih Wu, MD, Prakash Deedwania, MD, Thomas E. Love, PhD, Michel White, MD, Wilbert S. Aronow, MD, Stefan D. Anker, MD, PhD, Richard M. Allman, MD, Ali Ahmed, MD, MPH The American Journal of Medicine Volume 129, Issue 11, Pages 1178-1184 (November 2016) DOI: 10.1016/j.amjmed.2016.06.018 Copyright © 2016 Terms and Conditions

Figure 1 Love plot displaying absolute standardized differences comparing 34 baseline characteristics between heart failure patients with and without 30-day all-cause readmission, before and after propensity score matching. ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker. The American Journal of Medicine 2016 129, 1178-1184DOI: (10.1016/j.amjmed.2016.06.018) Copyright © 2016 Terms and Conditions

Figure 2 Kaplan-Meier plot for all-cause mortality in a propensity-matched cohort of older heart failure patients with and without a 30-day all-cause readmission. CI = confidence interval; HR = hazard ratio. The American Journal of Medicine 2016 129, 1178-1184DOI: (10.1016/j.amjmed.2016.06.018) Copyright © 2016 Terms and Conditions